Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Free Cash Flow: 2022-2025

Historic Free Cash Flow for Praxis Precision Medicines (PRAX) over the last 4 years, with Sep 2025 value amounting to -$65.0 million.

  • Praxis Precision Medicines' Free Cash Flow fell 136.54% to -$65.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$228.9 million, marking a year-over-year decrease of 130.08%. This contributed to the annual value of -$131.8 million for FY2024, which is 18.50% down from last year.
  • According to the latest figures from Q3 2025, Praxis Precision Medicines' Free Cash Flow is -$65.0 million, which was down 18.97% from -$54.7 million recorded in Q2 2025.
  • In the past 5 years, Praxis Precision Medicines' Free Cash Flow registered a high of -$20.9 million during Q1 2024, and its lowest value of -$65.0 million during Q3 2025.
  • Its 3-year average for Free Cash Flow is -$37.8 million, with a median of -$31.2 million in 2023.
  • Per our database at Business Quant, Praxis Precision Medicines' Free Cash Flow skyrocketed by 48.26% in 2023 and then crashed by 154.47% in 2025.
  • Quarterly analysis of 4 years shows Praxis Precision Medicines' Free Cash Flow stood at -$28.8 million in 2022, then climbed by 17.17% to -$23.9 million in 2023, then slumped by 135.20% to -$56.1 million in 2024, then plummeted by 136.54% to -$65.0 million in 2025.
  • Its Free Cash Flow was -$65.0 million in Q3 2025, compared to -$54.7 million in Q2 2025 and -$53.1 million in Q1 2025.